Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Escandine
2. Ibopamine Hydrochloride
3. Inopamil
4. N-methyldopamine Diisobutyrate
5. Propanoic Acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene Ester
6. Sb 7505
7. Sb-7505
1. 66195-31-1
2. Sb 7505
3. 4-(2-(methylamino)ethyl)-o-phenylene Diisobutyrate
4. 8zca2i2l11
5. Propanoic Acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene Ester
6. Sb-7505
7. Ibopamino [inn-spanish]
8. Sb 7505; Sb 7505 (pharmaceutical); Skf 100168
9. Ibopaminum
10. Ibopamino
11. 4-(2-(methylamino)ethyl)-1,2-phenylene Bis(2-methylpropanoate)
12. Ibopaminum [inn-latin]
13. Einecs 266-229-5
14. Skf 100168
15. Unii-8zca2i2l11
16. Ibopamine [usan:inn:ban]
17. Trazyl
18. 4-(2-(methylamino)ethyl)-2-phenylendiisobutyrat
19. Ibopamine [inn]
20. Ibopamine [mi]
21. Ibopamine (usan/inn)
22. Ibopamine [usan]
23. Ibopamine [mart.]
24. [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate
25. Ibopamine [who-dd]
26. Schembl147258
27. Chembl307739
28. Dtxsid3023138
29. Chebi:135306
30. Zinc1542906
31. Db13316
32. D04488
33. L013392
34. Q5984366
35. 4-[2-(methylamino)ethyl]benzene-1,2-diyl Bis(2-methylpropanoate)
36. 5-[2-(methylamino)ethyl]-2-[(2-methylpropanoyl)oxy]phenyl 2-methylpropanoate
Molecular Weight | 307.4 g/mol |
---|---|
Molecular Formula | C17H25NO4 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 307.17835828 g/mol |
Monoisotopic Mass | 307.17835828 g/mol |
Topological Polar Surface Area | 64.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Diuretics
Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)
C - Cardiovascular system
C01 - Cardiac therapy
C01C - Cardiac stimulants excl. cardiac glycosides
C01CA - Adrenergic and dopaminergic agents
C01CA16 - Ibopamine
S - Sensory organs
S01 - Ophthalmologicals
S01F - Mydriatics and cycloplegics
S01FB - Sympathomimetics excl. antiglaucoma preparations
S01FB03 - Ibopamine
Global Sales Information
ABOUT THIS PAGE
A Ibopamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibopamine, including repackagers and relabelers. The FDA regulates Ibopamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibopamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ibopamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ibopamine supplier is an individual or a company that provides Ibopamine active pharmaceutical ingredient (API) or Ibopamine finished formulations upon request. The Ibopamine suppliers may include Ibopamine API manufacturers, exporters, distributors and traders.
click here to find a list of Ibopamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ibopamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ibopamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ibopamine GMP manufacturer or Ibopamine GMP API supplier for your needs.
A Ibopamine CoA (Certificate of Analysis) is a formal document that attests to Ibopamine's compliance with Ibopamine specifications and serves as a tool for batch-level quality control.
Ibopamine CoA mostly includes findings from lab analyses of a specific batch. For each Ibopamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ibopamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ibopamine EP), Ibopamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ibopamine USP).
LOOKING FOR A SUPPLIER?